Eun Young Han1, Min Ho Chun2, Bo Ryun Kim1, Ha Jeong Kim2. 1. Department of Rehabilitation Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea. 2. Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Abstract
OBJECTIVE: To confirm functional improvement in brain tumor patients after 4-week conventional rehabilitation therapy, to compare the cognitive impairment of brain tumor patients with subacute stroke patients using computerized neuropsychological testing, and to determine the effects on functional outcomes of daily activity. METHODS: From April 2008 to December 2012, 55 patients (29 brain tumor patients and 26 subacute stroke patients) were enrolled. All patients were assessed with a computerized neuropsychological test at baseline. Motricity Index, Korean version of Mini Mental Status Examination, and Korean version of Modified Barthel Index scores were assessed at the beginning and end of 4-week rehabilitation. Conventional rehabilitation therapy was applied to both groups for 4 weeks. RESULTS: Functional outcomes of all patients in both groups significantly improved after 4-week rehabilitation therapy. In brain tumor patients, the initial Motricity Index, cognitive dysfunction, and visual continuous performance test correction numbers were strong predictors of initial daily activity function (R(2)=0.778, p<0.01). The final Motricity Index and word-black test were strong predictors of final daily activity function (R(2)=0.630, p<0.01). In patients with subacute stroke, the initial Motricity index was an independent predictor of initial daily activity function (R(2)=0.245, p=0.007). The initial daily activity function and color of color word test were strong predictors of final daily activity function (R(2)=0.745, p<0.01). CONCLUSION: Conventional rehabilitation therapy induced functional improvement in brain tumor patients. Objective evaluation of cognitive function and comprehensive rehabilitation including focused cognitive training should be performed in brain tumor patients for improving their daily activity function.
OBJECTIVE: To confirm functional improvement in brain tumorpatients after 4-week conventional rehabilitation therapy, to compare the cognitive impairment of brain tumorpatients with subacute stroke patients using computerized neuropsychological testing, and to determine the effects on functional outcomes of daily activity. METHODS: From April 2008 to December 2012, 55 patients (29 brain tumorpatients and 26 subacute stroke patients) were enrolled. All patients were assessed with a computerized neuropsychological test at baseline. Motricity Index, Korean version of Mini Mental Status Examination, and Korean version of Modified Barthel Index scores were assessed at the beginning and end of 4-week rehabilitation. Conventional rehabilitation therapy was applied to both groups for 4 weeks. RESULTS: Functional outcomes of all patients in both groups significantly improved after 4-week rehabilitation therapy. In brain tumorpatients, the initial Motricity Index, cognitive dysfunction, and visual continuous performance test correction numbers were strong predictors of initial daily activity function (R(2)=0.778, p<0.01). The final Motricity Index and word-black test were strong predictors of final daily activity function (R(2)=0.630, p<0.01). In patients with subacute stroke, the initial Motricity index was an independent predictor of initial daily activity function (R(2)=0.245, p=0.007). The initial daily activity function and color of color word test were strong predictors of final daily activity function (R(2)=0.745, p<0.01). CONCLUSION: Conventional rehabilitation therapy induced functional improvement in brain tumorpatients. Objective evaluation of cognitive function and comprehensive rehabilitation including focused cognitive training should be performed in brain tumorpatients for improving their daily activity function.
Authors: Karin Gehring; Neil K Aaronson; Martin J Taphoorn; Margriet M Sitskoorn Journal: Expert Rev Anticancer Ther Date: 2010-11 Impact factor: 4.512
Authors: Marco Ronald Hassler; Katarzyna Elandt; Matthias Preusser; Johann Lehrner; Petra Binder; Karin Dieckmann; Andrea Rottenfusser; Christine Marosi Journal: J Neurooncol Date: 2009-09-10 Impact factor: 4.130
Authors: Karin Gehring; Margriet M Sitskoorn; Chad M Gundy; Sietske A M Sikkes; Martin Klein; Tjeerd J Postma; Martin J van den Bent; Guus N Beute; Roelien H Enting; Arnoud C Kappelle; Willem Boogerd; Theo Veninga; Albert Twijnstra; Dolf H Boerman; Martin J B Taphoorn; Neil K Aaronson Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: J F Lehmann; J A DeLisa; C G Warren; B J deLateur; P L Bryant; C G Nicholson Journal: Arch Phys Med Rehabil Date: 1978-09 Impact factor: 3.966
Authors: Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers Journal: Lancet Oncol Date: 2009-10-02 Impact factor: 41.316
Authors: Kelsey A Potter-Baker; Daniel P Janini; Yin-Liang Lin; Vishwanath Sankarasubramanian; David A Cunningham; Nicole M Varnerin; Patrick Chabra; Kevin L Kilgore; Mary Ann Richmond; Frederick S Frost; Ela B Plow Journal: J Spinal Cord Med Date: 2017-08-07 Impact factor: 1.985
Authors: Julia Day; David C Gillespie; Alasdair G Rooney; Helen J Bulbeck; Karolis Zienius; Florien Boele; Robin Grant Journal: Curr Treat Options Neurol Date: 2016-05 Impact factor: 3.598
Authors: Christina Weyer-Jamora; Melissa S Brie; Tracy L Luks; Ellen M Smith; Shawn L Hervey-Jumper; Jennie W Taylor Journal: Neurosurgery Date: 2021-11-18 Impact factor: 5.315
Authors: Pearl J C van Lonkhuizen; Kete M Klaver; Jeffrey S Wefel; Margriet M Sitskoorn; Sanne B Schagen; Karin Gehring Journal: Eur J Cancer Care (Engl) Date: 2019-05-14 Impact factor: 2.328
Authors: Marijke B Coomans; Linda Dirven; Neil K Aaronson; Brigitta G Baumert; Martin Van Den Bent; Andrew Bottomley; Alba A Brandes; Olivier Chinot; Corneel Coens; Thierry Gorlia; Ulrich Herrlinger; Florence Keime-Guibert; Annika Malmström; Francesca Martinelli; Roger Stupp; Andrea Talacchi; Michael Weller; Wolfgang Wick; Jaap C Reijneveld; Martin J B Taphoorn Journal: Neuro Oncol Date: 2019-11-04 Impact factor: 12.300
Authors: Anna Kelm; Nico Sollmann; Sebastian Ille; Bernhard Meyer; Florian Ringel; Sandro M Krieg Journal: Front Oncol Date: 2017-08-18 Impact factor: 6.244